The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Shah
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Integrated Proteins Limited informed the BSE that Ashish Shah, a non-promoter acquirer, has acquired 9,30,000 equity shares of the company through a preferential allotment on August 7, 2025. This represents 4.97% of the company's total voting/share capital. Before this acquisition, Ashish Shah held NIL shares in the company. The preferential allotment significantly expanded the company's equity base from 32,03,600 shares (Rs. 3.20 crore) to 1,87,13,600 shares (Rs. 18.71 crore), indicating a major capital infusion. Ashish Shah does not belong to the promoter/promoter group and the holding is purely in equity shares with no encumbrance.
This is a fresh equity infusion into the company via preferential allotment from a non-promoter investor, strengthening the capital base. For existing shareholders, this means dilution of their stake (share capital expanded nearly 6x), but also signals new investor interest. Ashish Shah's 4.97% holding places him just below the 5% SAST disclosure threshold, meaning any further small purchases could trigger additional disclosure obligations.